Related Experiment Video
Updated: May 21, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial
Jordan J Elm1, Yuko Y Palesch, Gary G Koch
1Medical University of South Carolina, Charleston, SC, USA. elmj@musc.edu
Journal of Biopharmaceutical Statistics
|June 2, 2012
Summary
Adding new treatment arms mid-study requires careful analysis. Adaptive methods offer flexibility and power, outperforming simple data pooling in clinical trials.
Area of Science:
- Clinical trial methodology
- Biostatistics
- Pharmaceutical development
Background:
- Multiple experimental drugs often progress concurrently for a single disease.
- Clinical trials may need to incorporate new treatment arms after initiation.
Purpose of the Study:
- To evaluate analytical methods for clinical trials where a new treatment arm is added mid-study.
- To compare the statistical performance of different approaches under various conditions.
Main Methods:
- Monte Carlo simulations were employed to assess analytical strategies.
- Methods compared included a linear model with stage adjustment, data pooling, and adaptive combination tests.
- Analyses focused on pairwise comparisons of means in independent normal populations.
Main Results:
- Data pooling inflates Type I error rates and reduces power when intra-stage correlation or fixed stage effects are present.
- A linear model adjusting for stage effects demonstrates greater statistical power.
- Adaptive methods provide flexibility, including the ability to re-estimate sample size.
Conclusions:
- Adding treatment arms mid-study can lead to cost savings by integrating emerging therapies.
- Adaptive statistical approaches are recommended for their power and flexibility in such dynamic trial designs.
- Careful consideration of analytical methods is crucial to maintain trial integrity when modifying study designs.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...